Back to search
Hereditary Breast/Ovarian Cancer (brca1, brca2)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Breast/Ovarian Cancer (brca1, brca2) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Breast/Ovarian Cancer (brca1, brca2) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The aim of the COVAR project is to achieve reliable classification of as many variants of interest as possible from the French OncoGenetics Database (FrOG, http…
The goal of this study is to understand the performance of an experimental blood test that aims to detect early tumors in patients with hereditary cancer syndro…
The objective of this protocol is to develop an institution-wide liquid biopsy protocol that will establish a common process for collecting blood and correspond…
Ovarian cancer is the gynecological malignancy with the highest fatality rate, seriously threatening the life and health of women. One of the main reasons for i…
RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop…
Individuals and families with known or suspected syndromes that include breast, ovarian or genetically-related cancers are enrolled in this family study, which…
This clinical trial studies whether a web-based program, Kindred, works to improve the understanding of genetic cancer risk and cancer genetic testing in Africa…